Pediatrix Medical Group, Inc. (CH:PDC)
NYSE:PDC
Total Valuation
Pediatrix Medical Group has a market cap or net worth of CHF1.42B. The enterprise value is $2.19B.
Market CapCHF1.42B
Enterprise Value$2.19B
Share Statistics
Pediatrix Medical Group has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders1.54%
Owned by Institutions17.49%
Financial Efficiency
Pediatrix Medical Group’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 9.67%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.67%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee464.53K
Profits Per Employee0.00
Employee Count4,120
Asset Turnover0.85
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pediatrix Medical Group is 10.7. Pediatrix Medical Group’s PEG ratio is -0.04.
PE Ratio10.7
PS Ratio0.95
PB Ratio2.11
Price to Fair Value2.11
Price to FCF7.22
Price to Operating Cash Flow7.17
PEG Ratio-0.04
Income Statement
In the last 12 months, Pediatrix Medical Group had revenue of 1.91B and earned 165.39M in profits. Earnings per share was 1.94.
Revenue1.91B
Gross Profit471.88M
Operating Income231.09M
Pretax Income216.43M
Net Income165.39M
EBITDA274.22M
Earnings Per Share (EPS)1.94
Cash Flow
In the last 12 months, operating cash flow was 259.05M and capital expenditures -21.39M, giving a free cash flow of 237.66M billion.
Operating Cash Flow259.05M
Free Cash Flow237.66M
Free Cash Flow per Share10.00T>
Dividends & Yields
Pediatrix Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Pediatrix Medical Group upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Pediatrix Medical Group as a current ratio of 1.66, with Debt / Equity ratio of 71.67%
Current Ratio1.66
Quick Ratio1.66
Debt to Market Cap0.35
Net Debt to EBITDA1.04
Interest Coverage Ratio6.43
Taxes
In the past 12 months, Pediatrix Medical Group has paid 51.04M in taxes.
Income Tax51.04M
Effective Tax Rate0.24
Enterprise Valuation
Pediatrix Medical Group EV to EBITDA ratio is 7.69, with an EV/FCF ratio of 8.35.
EV to Sales1.10
EV to EBITDA7.69
EV to Free Cash Flow8.35
EV to Operating Cash Flow7.78
Balance Sheet
Pediatrix Medical Group has CHF328.97M in cash and marketable securities with CHF629.72M in debt, giving a net cash position of -CHF300.74M billion.
Cash & Marketable SecuritiesCHF328.97M
Total DebtCHF629.72M
Net Cash-CHF300.74M
Net Cash Per Share-CHF10.00T>
Tangible Book Value Per Share-CHF4.83
Margins
Gross margin is 25.80%, with operating margin of 12.07%, and net profit margin of 8.64%.
Gross Margin25.80%
Operating Margin12.07%
Pretax Margin11.31%
Net Profit Margin8.64%
EBITDA Margin14.33%
EBIT Margin13.19%
Analyst Forecast
The average price target for Pediatrix Medical Group is CHF19.14, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF19.14
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast―